穴位贴敷辅助舒肝解郁胶囊合黄连阿胶汤加味治疗冠心病心绞痛合并心肾不交型抑郁症临床研究  

Clinical Study on Point Application Assisting Modified Shugan Jieyu Capsules and Huanglian Ejiao Tang for Coronary Heart Disease Angina Complicated with Depression of Non-Interaction Between the Heart and Kidney Type

作　　者：项雪春 章顺安 孙彦 XIANG Xuechun;ZHANG Shun'an;SUN Yan

机构地区：[1]宁波市北仑区人民医院,浙江宁波315800

出　　处：《新中医》2021年第5期167-170,共4页New Chinese Medicine

摘　　要：目的:观察穴位贴敷辅助舒肝解郁胶囊合黄连阿胶汤加味治疗冠心病心绞痛合并心肾不交型抑郁症的临床疗效。方法:将62例冠心病心绞痛合并抑郁症患者按随机数字表法分为对照组和观察组各31例。2组均给予冠心病常规治疗,对照组给予舒肝解郁胶囊、黄连阿胶汤加味治疗,观察组在对照组基础上给予穴位贴敷治疗。比较2组临床疗效、汉密尔顿抑郁量表(HAMD)-17评分、抑郁自评量表(SDS)评分、症状自评量表(SCL-90)及贝克抑郁自评量表(BDI)评分。结果:观察组总有效率为93.55%,高于对照组67.74%,差异有统计学意义(P<0.05)。治疗前,2组HAMD-17评分、SDS评分、SCL-90评分及BDI评分比较,差异均无统计学意义(P>0.05)。治疗后,2组HAMD-17评分、SDS评分、SCL-90评分及BDI评分较治疗前降低(P<0.05),且观察组各项评分均低于对照组(P<0.05)。结论:穴位贴敷辅助舒肝解郁胶囊合黄连阿胶汤加味治疗冠心病心绞痛合并心肾不交型抑郁症的临床疗效较好,可以改善患者的抑郁症状。Objective: To observe the clinical effect of point application assisting modified Shugan Jieyu capsules and Huanglian Ejiao tang for coronary heart disease angina complicated with depression of non-interaction between the heart and kidney type. Methods:A total of 62 cases of patients with coronary heart disease angina complicated with depression were divided into the control group and the observation group according to the random number table method,31 cases in each group. Both groups were given routine treatment for coronary heart disease;the control group was additionally given modified treatment of Shugan Jieyu capsules and Huanglian Ejiao tang,and the observation group was additionally treated with point application based on the treatment of the control group. The clinical effect and the scores of Hamilton Depression Scale(HAMD-17), Self-Rating Depression Scale(SDS), Symptom Checklist-90(SCL-90) and Beck Depression Inventory(BDI) in the two groups were compared. Results:The total effective rate was 93.55% in the observation group,higher than that of 67.74% in the control group, the difference being significant(P<0.05). Before treatment, there was no significant difference being found in the comparison of the scores of HAMD-17, SDS, SCL-90 and BDI between the two groups(P>0.05). After treatment, the scores of HAMD-17, SDS, SCL-90 and BDI in the two groups were decreased when compared with those before treatment,and the scores in the observation group were lower than those in the control group(P<0.05). Conclusion:The treatment of point application assisting modified Shugan Jieyu capsules and Huanglian Ejiao tang has better clinical effect in treating coronary heart disease angina complicated with depression of non-interaction between the heart and kidney type,which can improve the depressive symptoms of patients.

关 键 词：冠心病心绞痛 抑郁症 心肾不交型 黄连阿胶汤 舒肝解郁胶囊 穴位贴敷 汉密尔顿抑郁量表 症状自评量表 

分 类 号：R541.4[医药卫生—心血管疾病] R749.41[医药卫生—内科学]